3 ms·
It's fair to exclude vulnerable non-recurring revenue such as regulatory credits to get a better picture of a companies health. But if you do that, you also ne
by bryanlarsen 6y ago
It's fair to exclude vulnerable non-recurring revenue such as regulatory credits to get a better picture of a companies health. But if you do that, you also need to exclude vulnerable non-recurring expense as well -- aka the stock-based compensation which has no impact on cash and will disappear if the company stops growing.
- itsoktocry 6y agoI'll bet you it will be a long time before stock based compensation slows down. It's part of the game.
- bryanlarsen 6y agoElon gets $0 without revenue growth. https://electrek.co/2020/05/28/tesla-elon-musk-first-tranche-compensation-plan-worth-million/ https://electrek.co/2020/05/28/tesla-elon-musk-first-tranche...
- itsoktocry 6y agoIt's mostly market cap based, says so right in the article you linked.
- bryanlarsen 6y agoHe's already hit the market cap goal for the 12th milestone. It's the EBITDA goal that's holding him back from collecting all of them.
- itsoktocry 6y agoFYI, apparently the adjusted EPS number adds back stock comp, but doesn't remove the reg credits.